Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001720165 | SCV000522947 | likely benign | not provided | 2018-12-10 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001191144 | SCV001358848 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-03-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001395258 | SCV001596962 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-09-06 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001191144 | SCV002042017 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-07-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001191144 | SCV002679971 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-10-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004000382 | SCV004844931 | likely benign | Marfan syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing |